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ABSTRACT No large study has described the seasonal variation in asthma attacks in population-based
asthmatics in whom sensitisation to allergen has been measured.
2637 young adults with asthma living in 15 countries reported the months in which they usually had
attacks of asthma and had skin-prick tests performed. Differences in seasonal patterns by sensitisation status
were assessed using generalised estimating equations.
Most young adults with asthma reported periods of the year when their asthma attacks were more common
(range: 47% in Sweden to 86% in Spain). Seasonal variation in asthma was not modified by sensitisation to
house dust mite or cat allergens. Asthmatics sensitised to grass, birch and Alternaria allergens had different
seasonal patterns to those not sensitised to each allergen, with some geographical variation. In southern
Europe, those sensitised to grass allergens were more likely to report attacks occurred in spring or summer than
in winter (OR March/April 2.60, 95% CI 1.70–3.97; OR May/June 4.43, 95% CI 2.34–8.39) and smaller later
peaks were observed in northern Europe (OR May/June 1.25, 95% CI 0.60–2.64; OR July/August 1.66, 95% CI
0.89–3.10). Asthmatics reporting hay fever but who were not sensitised to grass showed no seasonal variations.
Seasonal variations in asthma attacks in young adults are common and are different depending on
sensitisation to outdoor, but not indoor, allergens.
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Introduction
As far back as the fifth century BC Hippocrates noted seasonal variation in exacerbations of asthma [1].
Seasonal patterns have been described for asthma mortality, hospital admissions and emergency department
visits [2–5], the variation being ascribed to seasonal variation in exposure to ambient allergens, respiratory
infections and meteorological changes [4, 6]. In older adults, asthma mortality and hospital admissions are
more common during the winter months (possibly explained by infections), and in the younger adult
population (a ‘‘more atopic’’ generation) are more common in periods of high ambient allergen load (grass
in the spring and summer; mould in the late summer and autumn) [7].
However, to date, no large study has described seasonal variation in population-based asthmatics who also
have information on IgE sensitisation. Small panel studies suggest asthma severity is worse in the pollen
season in those sensitised to grass [8, 9] and in winter in those sensitised to house dust mite [10].
Asthmatics presenting to accident and emergency departments in Spain in early summer (May–June) were
more likely to be sensitised to grass than those presenting in other months [11]. Similarly, mild, near fatal
and fatal asthma has been associated with sensitisation to Alternaria in months where Alternaria levels are
high [12, 13].
In this report we use information collected from participants in the European Community Respiratory
Health Survey (ECRHS), a large multicentre international study of young to middle-aged adults living in
differing climatic regions and in countries with marked variation in the prevalence of sensitisation to
environmental allergens [14]. The aim is to describe seasonal variation in asthma exacerbations in those
who are and are not sensitised to aeroallergens, to quantify the risk and to assess whether seasonal patterns
are consistent between countries.
Material and methods
The ECRHS I [15] recruited a random sample of at least 3000 adults aged 20–44 years, identified from a
population-based sampling frame in each participating centre. Each was sent a postal questionnaire and a
random sample of responders plus a sample of those with symptoms suggestive of asthma (symptomatic
sample) were invited for further tests. The postal survey, the clinical interview (at which skin-prick tests
(SPTs) were performed and blood samples taken) and the testing of samples for serum IgE were conducted
between 1991–1993.
Overall, 41 centres in 16 countries and on three continents (Europe, North America and Australasia)
followed the full protocol. Of the 24 115 participants (random and symptomatic sample), 3353 (13.9%)
reported they ‘‘ever had asthma’’. Of the participants that reported they ‘‘ever had asthma’’ 3151 (94.0%)
provided a complete response to the question ‘‘Which months of the year do you usually have attacks of
asthma?’’ (with a response of ‘‘no’’ or ‘‘yes’’ to each of the six bimonthly periods: January/February, March/
April, May/June, July/August, September/October and November/December). Overall, 2709 (86%) had
SPTs. In one centre (Iceland), the number of asthmatics with positive SPTs was insufficient for statistical
analysis, leaving 2637 asthmatics with information on seasonality and SPTs (2023 with serum specific IgE
and total IgE measures) (online supplementary figure S1).
SPTs to Timothy grass, Dermatophagoides pteronyssinus (house dust mite), cat, Cladosporium herbarum,
Alternaria alternata, birch and common ragweed were performed using Phazets, lancets precoated with
standardised lyophilised allergen extracts (Pharmacia Diagnostics AB, Uppsala, Sweden). SPTs were
considered positive if the mean wheal diameter (MWD) was .0 mm [16]. Serum samples were tested for
specific IgE (Timothy grass, house dust mite, cat and Cladosporium plus birch in Northern Europe,
Parietaria in Southern Europe, and ragweed in Australia and the USA) using the Pharmacia CAP System
(Pharmacia Diagnostics AB). Sensitisation was considered present if serum IgE was .0.35 kU?L-1. Due to
regulatory and ethical constraints, SPT to Timothy grass was not performed in Germany. Ethical permission
to conduct the study was granted by local ethics committees within each participating centre.
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Statistical analysis
Each participant was considered to have taken part in six surveys: one asking if they experienced asthma
attacks in January/February, another in which they were asked whether they experienced attacks in
March/April and so on. A marginal logistic regression model for binary outcomes, based on generalised
estimating equations, was used to generate the risk of reporting a particular 2-month period was associated
with attacks of asthma (with January/February as the reference category). This method, which
is appropriate for dealing with longitudinal and other correlated binary response data, generates
robust estimators regardless of the specification of the covariance matrix and, as autocorrelation
is included in the covariance, coefficients can be interpreted as usual. The bimonthly periods were
shifted 6 months forward for Australian and New Zealand centres to allow seasonal comparison across the
two hemispheres.
To examine whether these patterns were different in those who were and were not sensitised, an interaction
term (positive SPT to specific allergen no/yes 6 the six bimonthly periods) was included giving a total of
five interaction terms for each model. Where there was evidence of effect modification by sensitisation,
analyses were repeated stratified by sensitisation status. Throughout, adjustments for age, sex and
sensitisation to the allergens not under assessment (four of house dust mite, grass, cat, Alternaria and birch)
were included.
Analyses were conducted within countries, but as there were insufficient data within each country to
identify patterns clearly, results from each country were combined using meta-analytical techniques. Risk
estimates for each country within each of the three continents were combined in a random effects meta-
analysis [17] and heterogeneity tested using the Q statistic and I2. As there was evidence of heterogeneity in
Europe, European countries were further divided into central/north Europe and south Europe (defined by
¡50u latitude). As this geopolitical method of division Europe may not fully capture pollen exposures, we
also interrogated pollen maps (www.pollenwarndienst.at) to divide countries into those with 1) Poaceae
season starting before and after May or June and 2) countries where peak birch season levels were
.70.0 grains?m-3 (online supplementary table S1–2).
In sensitivity analyses, this was repeated, defining a positive SPT by MWD o3 mm, with sensitisation based
on serum IgE measures (using both .0.35 and .0.70 kU?L-1 cut-offs), with the sample restricted to
asthmatics who reported symptoms (wheezing, chest tightness, attack of shortness of breath coming on
during the day at rest and waking with shortness of breath) or the use of asthma medication in the last
12 months (n52423, 92%), and with inclusion of an adjustment for the month of interview. Effect
modification of seasonality of asthma attacks by high total IgE (.100 kU?L-1) and reported ‘‘hay fever or
nasal allergies’’ was also assessed.
All analyses were undertaken in Stata IC 10.1 (Stata software version 10.1; Stata Corp., College Station, TX, USA).
Results
Table 1 shows the number (range: 43 in Ireland to 387 in Canada), age and sex distributions of participants
with self-reported asthma in each country. Of these, 93% reported ‘‘physician diagnosed asthma’’. The
proportion of asthmatics sensitised to each allergen varied between countries in a pattern broadly similar to
that previously reported in the general population (table 1) [14]. Allergic sensitisation to allergens
associated with vegetation (grass and birch), indoor allergens (cat and dust) and moulds (Alternaria) was
prevalent in all countries. However, the prevalence of sensitisation to Cladosporium was low in all countries
except the USA (n512, 18%), Canada (n557, 15%), Sweden (n551, 14%) and the UK (n546, 13%).
Similarly, the prevalence of sensitisation to ragweed was low in most countries except Canada (n5104,
27%), the USA (n511, 16%) and the UK (n516, 4%). The small number of participants precluded
inclusion of the USA in analyses of variation by these two allergens.
Table 2 shows the proportion of asthmatics who, when asked, reported their attacks of asthma usually
occurred at specific times of the year and the adjusted odds ratio of reported asthma attacks in each
bimonthly period. In most countries, most participants reported seasonal variation in their asthma (range:
47% Sweden to 86% Spain; median: 70% in France, Switzerland, New Zealand). In some countries, there
was no clear overall seasonal pattern (e.g. France, Ireland, Germany and Norway), whereas in many
countries (e.g. Spain, Italy, Switzerland, Belgium, Sweden, the USA and Australia) a significant increased
risk of reported asthma attacks was seen in the spring or summer months (March/April and May/June)
compared to winter ones. In contrast, there was an overall decreased risk of asthma in the summer months
in the Netherlands, the UK, Canada and New Zealand (i.e. asthmatics reported their attacks of asthma
usually occurred in winter).
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There was no evidence that sensitisation to house dust mite or cat allergens modified the seasonal pattern of
reported asthma attacks in any of the countries or continents (p-value for interaction of bimonthly period
by sensitisation .0.05, I2 for variation between countries ,40%) (fig. 1a and b). In the few centres with
sufficient data, there was some suggestion of effect modification by having a positive SPT to ragweed
(Canada, UK) throughout the summer and early autumn (p,0.05 only in September/October) and by
having a positive SPT to Cladosporium in July/August (UK, Sweden and Canada) but formal testing showed
this to be below the conventional limits of statistical significance (fig. 1c and d).
In contrast, there was evidence that seasonal variation was modified by sensitisation to grass, birch and
Alternaria (online supplementary figures S2–S4 show meta-analysis of the interaction coefficients). In
figures 2–4, the odds of reporting asthma attacks in each bimonthly period are shown, stratified by
sensitisation status. There was considerable variation in Europe (for example, I2 for the interaction terms for
grass in May/June and birch sensitisation in March/April within Europe were 61% and 76%, respectively).
When Europe was considered as north and south, or divided based on available average pollen levels over the
past 15 years (early/late Poaceae season or by peak birch pollen levels reached) some differences still remained.
In both south and north Europe (fig. 2a and b), those sensitised to grass were more likely to report that
their asthma attacks usually occur in the spring/summer periods than in the winter period, while those who
were not sensitised were more likely to report attacks in the winter months. For those who were grass
sensitised, the higher risks were in early summer in southern Europe (OR March/April 2.60, 95% CI 1.70–
3.97; OR May/June 4.43, 95% CI 2.34–8.39), and by comparison, in northern Europe the peak risks were
relatively smaller, occurred later and showed more variation between the countries (OR July/August 1.66,
95% CI 0.89–3.10; I2 61%). Similar patterns were seen in Europe when countries were considered to have an
early or late grass pollen season (online supplementary fig. S5). In North America (fig. 2c), the pattern was
similar to that seen for southern Europe (although all interaction terms p.0.05). In Australia and New
Zealand (fig. 2d), the effect of grass sensitisation on asthma attacks was more complex, being different in
the two countries, and superimposed on an overall decreased risk of attacks during the summer or autumn
months. Formal testing for modification of the seasonal pattern by sensitisation to grass was significant
(p,0.05) only in March/April. In all regions, the seasonal pattern of asthma amongst those reporting ‘‘hay
fever or nasal allergies’’ (overall, 77% of asthmatics also reported hay fever) was similar to that seen for grass
TABLE 1 Demographic characteristics and the proportion of asthmatics with positive skin-prick test to each allergen, by
country (ordered by latitude)
Country Subjects n Females % Age Dust mite Timothy grass Cat Birch Alternaria
Southern Europe
Spain 190 53 31.7¡7.3 82 (43) 53 (28) 32 (17) 11 (6) 9 (5)
Italy 88 52 32.9¡6.9 27 (31) 41 (47) 20 (23) 19 (22) 12 (14)
France 273 51 33.1¡7.6 146 (53) 113 (41) 83 (30) 33 (12) 41 (15)
Switzerland 122 51 31.8¡6.7 37 (30) 75 (61) 37 (30) 58 (48) 11 (9)
Northern Europe
Germany 63 51 34.3¡7.4 23 (37) 28# (44) 22 (35) 23 (37) 6 (10)
Belgium 64 50 33.1¡7.0 56 (88) 23 (36) 21 (33) 11 (17) 7 (11)
The Netherlands 51 49 34.3¡7.9 34 (67) 16 (31) 9 (18) 11 (22) 2 (4)
Ireland 43 56 32.1¡7.0 36 (84) 12 (28) 7 (16) 1 (2) 3 (7)
UK 366 57 33.2¡7.0 217 (59) 179 (49) 131 (36) 44 (12) 84 (23)
Sweden 354 56 32.7¡7.5 107 (30) 165 (47) 219 (62) 167 (47) 48 (14)
Norway 60 48 33.1¡6.6 13 (22) 18 (30) 16 (27) 17 (28) 2 (3)
North America
USA 67 49 33.6¡6.8 36 (54) 31 (46) 31 (46) 18 (27) 23 (34)
Canada 387 61 33.1¡7.0 215 (56) 143 (37) 175 (45) 89 (23) 85 (22)
Australasia
New Zealand 303 57 34.3¡6.9 205 (68) 148 (49) 67 (22) 54 (18) 38 (13)
Australia 205 53 33.6¡6.8 150 (73) 111 (54) 73 (36) 19 (9) 39 (19)
Total 2637 55 33.2¡7.1 1384 (53) 1128 (44) 943 (36) 575 (22) 410 (16)
Data are presented as mean¡SD or n (%), unless otherwise stated. Centres: Spain (Barcelona, Galdakao, Albacete, Oviedo and Huelva); Italy (Pavia,
Turin and Verona); France (Paris, Grenoble, Bordeaux and Montpellier); Switzerland (Basel); Germany (Hamburg and Erfurt); Belgium (Antwerp
City and South Antwerp); Netherlands (Groningen, Geleen and Bergen-op-zoom); Ireland (Dublin); UK (Ipswich, Norwich, Cambridge and
Caerphilly); Sweden (Uppsala, Umea and Gothenburg); Norway (Bergen); USA (Portland); Canada (Winnepeg, Vancouver, Hamilton, Montreal,
Halifax and Prince Edward Island); New Zealand (Wellington, Christchurch and Hawkes Bay); Australia (Melbourne). #: based on serum IgE
measurement.
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sensitisation (54% of those with hay fever also had sensitisation to grass) (online supplementary fig. S5).
However, this pattern was only present in those sensitised to grass, and not seen in those who reported hay
fever but who were not sensitised to grass (fig. 3).
In Europe, asthmatics who were sensitised to birch were more likely to report that their attacks occurred in
the spring or summer than in the winter months. The seasonal pattern amongst those who were sensitised
to birch was clearly seen in northern Europe (OR May/June 2.94, 95% CI 1.92–4.50; OR July/August 2.01,
95% CI 1.38–2.94) (fig. 4b), although there was some variation between countries (e.g. OR May/June 0.87,
95% CI 0.55–1.37; I2: 72%). The pattern was seen in countries where peak birch pollen levels exceeded
70.0 grains?m-3 (online supplementary fig. S6), but again there was some variation in the magnitude of the
effect between countries. Compared to grass sensitisation, the peak risk in this sensitised group occurred
earlier in the year (fig 3b and fig. 4b). Some seasonal variation was also seen in southern Europe (where
birch pollen levels are generally lower). There was no evidence that sensitisation to birch modified seasonal
variation of asthma attacks in North America or Australasia (all interactions p.0.05; fig. 4c–d).
Asthmatics who were sensitised to Alternaria were at a greater risk of reporting asthma attacks in May/June
and July/August in southern Europe (fig. 5a) and in July/August in north Europe (fig. 5b). There was some
evidence of similar seasonal patterns of reporting asthma attacks in North America (fig. 5c) (formal testing
for interactions p,0.05 in July/August) and in Australasia (fig. 5d) the pattern was similar to that seen for
grass sensitisation.
None of the above observations were substantially altered by changing the definition of a positive SPT
(MWD o3 mm), by using serum specific IgE to define sensitisation (using a cut off of 0.35 or 0.70 kU?L-1),
by restricting the sample to those who had asthma symptoms in the past year or by including the month of
interview (and SPT) as a potential confounder. Furthermore, high levels of total IgE (.100 kU?mL-1) did
not influence seasonal variations (data not shown).
Discussion
This large study of .2500 young adults with asthma shows that a substantial proportion report seasonal
variation in their attacks of asthma, and that the pattern of the seasonal variation is dependent on whether
they are sensitised to pollens and moulds, but not indoor allergens. Asthmatics sensitised to grass, birch and
Alternaria show very different seasonal patterns to those not sensitised to these allergens. This is most clearly
seen for sensitisation to grass, where individuals who are sensitised report more attacks in the summer months
TABLE 2 The proportion of participants with information who reported their asthma attacks occurred at specific bimonthly
periods of the year and the adjusted odds ratio of reporting that asthma attacks usually occur in a given bimonthly period by
country#
Country Asthma attacks at
specific bimonthly
periods %
OR
Jan/Feb
OR
March/April
OR
May/June
OR
July/Aug
OR
Sept/Oct
OR
Nov/Dec
Spain 86 1.00 1.54 0.94 0.47 0.90 1.11
Italy 85 1.00 1.54 2.44 1.10 0.81 0.81
France 70 1.00 0.97 1.06 0.74 0.67 0.88
Switzerland 70 1.00 1.74 2.36 1.18 1.07 0.97
Germany 76 1.00 1.05 1.15 0.95 1.05 1.15
Belgium 67 1.00 1.57 2.35 1.79 2.05 1.91
The Netherlands 75 1.00 1.00 0.37 0.34 0.85 1.09
Ireland 79 1.00 0.35 0.44 0.82 0.74 1.11
UK 61 1.00 0.63 0.84 0.97 0.72 1.00
Sweden 47 1.00 1.09 1.48 1.04 0.91 1.09
Norway 50 1.00 0.86 0.74 1.18 0.86 0.74
USA 72 1.00 0.83 2.38 1.00 1.06 0.89
Canada 79 1.00 0.70 0.81 0.80 0.79 0.91
New Zealand" 70 1.00 0.71 0.45 0.37 0.44 1.00
Australia" 59 1.00 1.66 1.07 0.77 0.59 0.81
Odds ratio coefficients from generalised estimating equations models controlling for repeated individual observations, sex and age. #: without
consideration of sensitisation to aeroallergen; ": bimonthly periods have been shifted 6 months forward to allow comparison with the northern
hemisphere. Statistically significant results (p,0.05) are shown in bold.
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(most likely related to allergen exposure) and those who are not sensitised report more attacks in the winter
months (most likely due to the effects of respiratory infections [6]). Although these patterns are widely
recognised by clinicians, to date, no epidemiological study of this scale has described these patterns, or derived
risk estimates associated with sensitisation status in representative samples of the asthmatic population.
Beyond the clear relevance for clinical practice, our results provide important baseline information for risk
assessment in relation to climate change and may assist in the interpretation of health effects of outdoor air
pollution on asthma.
We would expect the seasonal pattern in those who are sensitised to pollens and mould to mirror the
patterns of exposure. We do not have complete information on pollen levels in all of our participating
centres for the period of data collection (1991–1992). Two groups (the European Academy of Allergy and
Clinical Immunology and the International Association of Aerobiology) collated all available pollen data
from Europe (1974–1988) [18], which showed peak grass (Poaceae) pollen counts occurred later in
northern than southern Europe, and in some countries (e.g. northern Italy) were raised well into September/
October. In Scandinavian countries, the birch pollen season began in May, lasting at least until the end of
August, while the season was earlier, shorter and more intense in ‘‘southern’’ Europe. The ‘‘average’’ pollen
season over the last 15 years is broadly similar to these patterns (www.pollenwarndienst.at) and more recent
European work confirms these temporal and geographical variations in grass pollen [19, 20], birch [21] and
mould spore counts (Alternaria and Cladosporium) [22, 23]. However, there is growing evidence that
measurement of pollen allergenicity (a subject of research within multicentre initiatives such as the Health
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FIGURE 1 The overall adjusted odds ratio (error bars represent 95% confidence intervals) of asthma usually occurring in
each bimonthly period in those sensitised to a) house dust mite in all countries; b) cat in all countries; c) Cladosporium in
Sweden, the UK and Canada; and d) ragweed in the UK and Canada. Overall adjusted odds ratios are from meta-analysis
of interaction coefficients from generalised estimating equations models conducted within country controlling for
repeated individual observations, main effect of relevant allergen and bimonthly periods, sex, age and sensitisation to dust
mite (for cat), cat (for house dust mite) and grass, birch and Alternaria. j/f: January/February; m/a: March/April; m/j:
May/June; j/a: July/August; s/o: September/October; n/d: November/December.
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Impacts of Airborne Allergen Information Network; www.hialine.com), rather than pollen counts, may be
the relevant exposure to explain allergen associated variations in asthma exacerbations [24].
Our report suggests that mortality and admissions are the ‘‘tip of the iceberg’’ of seasonal variations in
asthma. Most asthma treatment guidelines list exposure to seasonal allergens as a potential trigger to asthma
attacks [25], and our data support that those with sensitisation to grass, birch and Alternaria (and possibly
Cladosporium) may benefit from focussed clinical protocols [26] that increase inhaled treatment during the
months of peak exposure to allergen. They may even benefit from desensitisation and immunotherapy
(2.6% of asthmatics reported they ‘‘had been vaccinated for allergy in the previous 12 months’’).
Assessment of sensitisation by SPTs and/or serum measures may not be routinely performed in all primary
healthcare settings. However, the interpretation of such testing requires understanding of potential cross-
reactivity and should be carefully considered alongside information on likely exposure. For example, some
people may test positive to ragweed in the UK, but ragweed pollen is absent there. Sensitisation probably
arises from cross-reactivity with other members of the Compositae (Asteraceae) family (e.g. mugwort). Even
though our data suggest that people with positive SPTs to ragweed in the UK and Canada have different
seasonal patterns, particularly in late summer, compared to those without positive SPTs (fig. 1d), this might
be explained by residual confounding by mould exposure. Similarly, the pattern of variation that we have
seen in those who do and do not have positive SPTs to birch in southern Europe may in part be explained
by cross-reactivity with other members of the Bet v 1-family (e.g. hazel and hop-hornbeam) [27].
Asthmatics who also reported hay fever showed an increased risk of reporting exacerbations in the spring
and summer months but this was limited to those who were grass sensitised. Although reporting hay fever
identifies those at greater risk of spring/summer asthma exacerbations (online supplementary fig. E7), the
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FIGURE 2 The overall adjusted odds ratio (error bars represent 95% confidence intervals) of asthma usually occurring in
each bimonthly period in those sensitised to grass and in those not sensitised to grass in a) south Europe; b) north
Europe; c) North America; and d) Australasia (bimonthly periods have been shifted 6 months forward to allow
comparison with the northern hemisphere). Overall adjusted odds ratios are from meta-analysis of bimonthly period
coefficients from generalised estimating equations models conducted within country controlling for repeated individual
observations, sex, age and sensitisation to dust, cat, Alternaria and birch. j/f: January/February; m/a: March/April; m/j:
May/June; j/a: July/August; s/o: September/October; n/d: November/December. #: p-heterogeneity ,0.05; *: p-value for
interaction ,0.05.
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addition of testing for grass sensitisation may be more useful to identify those at risk (fig. 3). Indoor
allergens, such as house dust mite and cat, may have a role in determining asthma exacerbations and
severity of disease, but our data suggest that those sensitised to indoor allergens have the same seasonal
variations as those who are not sensitised to these allergens.
Large time series and ecological studies of asthma mortality and admissions in relation to pollen or mould
exposure [7, 28–32] present effect estimates for the entire population and have not included differences in
effect in those who are and are not sensitised (the proportion of which varies between countries). The effect
of pollen on sensitised individuals may confound the respiratory effects of other outdoor pollutants,
particularly ozone (which peaks during the summer months). This could explain the inconsistency in the
association of ozone with asthma reported in some time series studies [33, 34]. Possible interactions
between air pollutants and aeroallergens and their effect on asthma exacerbations have been investigated in
few studies. Individual sensitisation to such aeroallergens might influence the observed effects and explain
why such interactions are only seen in some studies [35].
Climate change may lead to more intense and extended pollen or mould seasons with higher absolute levels
and increased allergenicity [36, 37]. There may be more thunderstorms, which are known to cause sudden
peaks in grass and mould allergen levels and ‘‘epidemic asthma’’ in those who are sensitised [11, 38]. This
report provides baseline information showing that those who are sensitised are indeed a subgroup of the
population who will be particularly at risk if these climatic changes occur.
The ideal study design to investigate the effects of pollen exposure on asthma exacerbations is a longitudinal
or panel study of asthmatics who provide symptom and sensitisation information at regular intervals over a
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FIGURE 3 The overall adjusted odds ratio (error bars represent 95% confidence intervals) of asthma usually occurring in
each bimonthly period in those with reported hay fever sensitised and not sensitised to grass in a) south Europe; b) north
Europe; c) North America; and d) Australasia (bimonthly periods have been shifted 6 months forward to allow
comparison with the northern hemisphere). Overall adjusted odds ratios are from meta-analysis of bimonthly period
coefficients from generalised estimating equations models conducted within country controlling for repeated individual
observations, sex, age (only among subjects with sensitisation to dust, cat, Alternaria and birch data). j/f: January/
February; m/a: March/April; m/j: May/June; j/a: July/August; s/o: September/October; n/d: November/December.
#: p-heterogeneity ,0.05.
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1-year period, but only one large study of this type (on children) has been reported [39]. Although our
study design is not optimal, it is, to our knowledge, the only large international study of seasonal variations
in population-based asthmatics in whom atopic status has been assessed. Participants were identified from
representative community based samples (not from hospital clinics) and even though the vast majority
reported a physician diagnosis of asthma, only a third reported using inhaled steroids in the past year
(reflecting that they had relatively mild disease [40] and the under-treatment of asthma during the 1990s).
We have relied on self-reported seasonality collected at one point in time, which has high face validity but
may introduce random error (making it more difficult to identify clear patterns). Systematic error is
unlikely as seasonal reporting was not influenced by month of interview or by participants knowing their
IgE status (questionnaire was asked before SPT).
Even though our report is based on observations made 20 years ago, similar patterns were still seen in adults
who took part in ECRHS II (a subsample of participants included in this report who were followed up in
2000–2002, n51284, aged 27–54 years at follow-up, 12 countries) who underwent repeat questionnaires
and limited serum IgE testing (no SPTs were performed in ECRHS II) (online supplementary fig. E8).
We have described geographical variation in seasonality but, because of the relatively small sample size in
some centres, have grouped information from centres to country level, and then regional level. Our regions
are thus defined by geopolitics rather than factors that others may consider more relevant (e.g. pollen levels,
climate and land usage).
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FIGURE 4 The overall adjusted odds ratio (error bars represent 95% confidence intervals) of asthma usually occurring in
each bimonthly period in those sensitised to birch and in those not sensitised to birch in a) south Europe; b) north
Europe (the Netherlands and Ireland were not included due to few asthmatics sensitised to birch producing a lack of
model convergence); c) North America; and d) Australasia (bimonthly periods have been shifted 6 months forward to
allow comparison with the northern hemisphere). Overall adjusted odds ratios are from meta-analysis of bimonthly
periods coefficients from generalised estimating equations models conducted within country controlling for repeated
individual observations, sex, age and sensitisation to grass, dust, cat and Alternaria. j/f: January/February; m/a: March/
April; m/j: May/June; j/a: July/August; s/o: September/October; n/d: November/December. #: p-heterogeneity ,0.05;
*: p-value for interaction ,0.05.
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In conclusion, we have shown that seasonal variation in asthma attacks in young adults is common and is
strongly associated with allergic sensitisation. This is a timely reminder to clinicians to remain alert to
seasonal allergens as a potential trigger for asthma attacks in their sensitised patients. Air pollution scientists
should strive to include measures of allergen exposure and measures of individual (or at least population
levels) of allergic sensitisation in their analyses. Climate change may increase pollen levels and their
allergenicity, and also extend pollen seasons; this will probably lead to increased exacerbations in those who
are sensitised to these aeroallergens. Large panel studies to better understand and quantify the relationships
between exacerbations, allergic sensitisation, directly measured pollen counts and other factors are required.
Acknowledgements
This paper is dedicated to the memory of Dr Michael (‘‘Mike’’) Burr.
References
1 Hippocrates. Aphorisms III. 19.22.
2 Khot A, Burn R. Seasonal variation and time trends of deaths from asthma in England and Wales 1960–82. Br Med J
(Clin Res Ed) 1984; 289: 233–234.
3 Fleming DM, Cross KW, Sunderland R, et al. Comparison of the seasonal patterns of asthma identified in general
practitioner episodes, hospital admissions, and deaths. Thorax 2000; 55: 662–665.
4 Silverman RA, Stevenson L, Hastings HM. Age-related seasonal patterns of emergency department visits for acute
asthma in an urban environment. Ann Emerg Med 2003; 42: 577–586.
1
0
-1
In
 (O
R
)
2
1.73
1.33
1.30
6.34a)
c) d)
b)
2.88
1.39
1.02
0.930.77
0.70
* *
-2
n/ds/oj/am/jm/aj/f
1
0
-1
In
 (O
R
)
2
0.83#
0.82#
1.02#
1.77
2.78
1.11
1.06
1.06
0.750.84
*
-2
n/ds/oj/am/jm/aj/f
■
■
■
■ ■
■
■
■
■■
■ ■
■
1
0
-1
In
 (O
R
)
2
0.85
0.68 1.00
1.88#
1.35
1.04 0.91
0.740.790.70
*
-2
n/ds/oj/am/jm/aj/f
1
0
-1
In
 (O
R
)
2
1.29
1.02#
0.62#
1.20
0.49#
0.62 1.09
0.87
0.48
0.74#
-2
n/ds/oj/am/jm/aj/f
■
■ ■
■
■
■ ■■
■
■ ■
■
◆
◆
◆ ◆
◆
◆
◆
◆ ◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
Sensitised
Not sensitised■
◆
FIGURE 5 The overall adjusted odds ratio (error bars represent 95% confidence intervals) of asthma usually occurring in
each bimonthly period in those sensitised to Alternaria and in those not sensitised to Alternaria in a) south Europe; b)
north Europe (the Netherlands, Belgium, Ireland and Norway were not included due to few asthmatics sensitised to
Alternaria producing a lack of model convergence); c) North America; and d) Australasia (bimonthly periods have been
shifted 6 months forward to allow comparison with the northern hemisphere). Overall adjusted odds ratios are from
meta-analysis of bimonthly periods coefficients from generalised estimating equations models conducted within country
controlling for repeated individual observations, sex, age and sensitisation to grass, dust, cat and birch. j/f: January/
February; m/a: March/April; m/j: May/June; j/a: July/August; s/o: September/October; n/d: November/December.
#: p-heterogeneity ,0.05; *: p-value for interaction ,0.05.
ENVIRONMENTAL LUNG DISEASE | C. CANOVA ET AL.
DOI: 10.1183/09031936.00097412944
5 Baibergenova A, Thabane L, Akhtar-Danesh N, et al. Effect of gender, age, and severity of asthma attack on patterns
of emergency department visits due to asthma by month and day of the week. Eur J Epidemiol 2005; 20: 947–956.
6 Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307:
982–986.
7 Huynh BT, Tual S, Turbelin C, et al. Short-term effects of airborne pollens on asthma attacks as seen by general
practitioners in the Greater Paris area, 2003–2007. Prim Care Respir J 2010; 19: 254–259.
8 Tilles SA, Bardana EJ Jr. Seasonal variation in bronchial hyperreactivity (BHR) in allergic patients. Clin Rev Allergy
Immunol 1997; 15: 169–185.
9 Britton J, Chinn S, Burney P, et al. Seasonal variation in bronchial reactivity in a community population. J Allergy
Clin Immunol 1988; 82: 134–139.
10 van der Heide S, De Monchy JG, De Vries K, et al. Seasonal differences in airway hyperresponsiveness in asthmatic
patients: relationship with allergen exposure and sensitization to house dust mites. Clin Exp Allergy 1997; 27: 627–633.
11 Galan I, Prieto A, Rubio M, et al. Association between airborne pollen and epidemic asthma in Madrid, Spain: a
case–control study. Thorax 2010; 65: 398–402.
12 Dharmage S, Bailey M, Raven J, et al. Mouldy houses influence symptoms of asthma among atopic individuals. Clin
Exp Allergy 2002; 32: 714–720.
13 O’Hollaren MT, Yunginger JW, Offord KP, et al. Exposure to an aeroallergen as a possible precipitating factor in
respiratory arrest in young patients with asthma. N Engl J Med 1991; 324: 359–363.
14 Bousquet PJ, Chinn S, Janson C, et al. Geographical variation in the prevalence of positive skin tests to
environmental aeroallergens in the European Community Respiratory Health Survey I. Allergy 2007; 62: 301–309.
15 Burney PG, Luczynska C, Chinn S, et al. The European Community Respiratory Health Survey. Eur Respir J 1994; 7:
954–960.
16 Chinn S, Jarvis D, Luczynska CM, et al. Measuring atopy in a multi-centre epidemiological study. Eur J Epidemiol
1996; 12: 155–162.
17 Bradburn M, Deeks J, Altman D. Metan – an alternative meta-analysis command (Metan 1.81). Stata Technical
Bulletin 2003; 44: 4–15.
18 D’Amato G, Spieksma FTM, Bonini S, eds. Allergenic Pollens and Pollinosis in Europe. Oxford, Wiley-Blackwell, 1991.
19 Emberlin J, Siegfried J, Dominguez-Vilches E, et al. Temporal and geographical variations in grass pollen seasons in
areas of western Europe: an analysis of season dates at sites of the European polleninformation system. Aerobiologia
2000; 16: 373–379.
20 D’Amato G, Cecchi L, Bonini S, et al. Allergenic pollen and pollen allergy in Europe. Allergy 2007; 62: 976–990.
21 Emberlin J, Detandt M, Gehrig R, et al. Responses in the start of Betula (birch) pollen seasons to recent changes in
spring temperatures across Europe. Int J Biometeorol 2002; 46: 159–170.
22 Ste˛palska D, Harmata K, Kasprzyk I, et al. Occurrence of airborne Cladosporium and Alternaria spores in Southern
and Central Poland in 1995–1996. Aerobiologia 1999; 15: 39–47.
23 Corden JM, Millington WM. The long-term trends and seasonal variation of the aeroallergen Alternaria in Derby,
UK. Aerobiologia 2001; 17: 127–136.
24 Buters JTM, Thibaudon M, Smith M, et al. Release of Bet v 1 from birch pollen from 5 European countries. Results
from the HIALINE study. Atmospheric Environment 2012; 55: 496–505.
25 Global Initiative for Asthma. Global strategy for asthma management and prevention. www.ginasthma.org/local/
uploads/files/GINA_report_March13.pdf Date last accessed: August, 2013. Date last updated: December, 2012.
26 Yawn BP. Factors accounting for asthma variability: achieving optimal symptom control for individual patients.
Prim Care Respir J 2008; 17: 138–147.
27 Hauser M, Asam C, Himly M, et al. Bet v 1-like pollen allergens of multiple Fagales species can sensitize atopic
individuals. Clin Exp Allergy 2011; 41: 1804–1814.
28 Dales RE, Cakmak S, Judek S, et al. Influence of outdoor aeroallergens on hospitalization for asthma in Canada.
J Allergy Clin Immunol 2004; 113: 303–306.
29 Atkinson RW, Strachan DP, Anderson HR, et al. Temporal associations between daily counts of fungal spores and
asthma exacerbations. Occup Environ Med 2006; 63: 580–590.
30 Erbas B, Chang JH, Dharmage S, et al. Do levels of airborne grass pollen influence asthma hospital admissions?Clin
Exp Allergy 2007; 37: 1641–1647.
31 Hanigan IC, Johnston FH. Respiratory hospital admissions were associated with ambient airborne pollen in
Darwin, Australia, 2004–2005. Clin Exp Allergy 2007; 37: 1556–1565.
32 Raphoz M, Goldberg MS, Garneau M, et al. Associations between atmospheric concentrations of spores and
emergency department visits for asthma among children living in Montreal. Arch Environ Occup Health 2010; 65:
201–210.
33 Sunyer J, Spix C, Quenel P, et al. Urban air pollution and emergency admissions for asthma in four European cities:
the APHEA Project. Thorax 1997; 52: 760–765.
34 Atkinson RW, Anderson HR, Sunyer J, et al. Acute effects of particulate air pollution on respiratory admissions:
results from APHEA 2 project. Air Pollution and Health: a European Approach. Am J Respir Crit Care Med 2001;
164: 1860–1866.
35 Cakmak S, Dales RE, Coates F. Does air pollution increase the effect of aeroallergens on hospitalization for asthma?
J Allergy Clin Immunol 2012; 129: 228–231.
36 Cecchi L, D’Amato G, Ayres JG, et al. Projections of the effects of climate change on allergic asthma: the
contribution of aerobiology. Allergy 2010; 65: 1073–1081.
37 Wolf J, O’Neill NR, Rogers CA, et al. Elevated atmospheric carbon dioxide concentrations amplify Alternaria
alternata sporulation and total antigen production. Environ Health Perspect 2010; 118: 1223–1228.
38 Venables KM, Allitt U, Collier CG, et al. Thunderstorm-related asthma – the epidemic of 24/25 June 1994. Clin Exp
Allergy 1997; 27: 725–736.
39 Dellavalle CT, Triche EW, Leaderer BP, et al. Effects of ambient pollen concentrations on frequency and severity of
asthma symptoms among asthmatic children. Epidemiology 2012; 23: 55–63.
40 Cazzoletti L, Marcon A, Janson C, et al. Asthma control in Europe: a real-world evaluation based on an
international population-based study. J Allergy Clin Immunol 2007; 120: 1360–1367.
ENVIRONMENTAL LUNG DISEASE | C. CANOVA ET AL.
DOI: 10.1183/09031936.00097412 945
